1. Home
  2. HSAI vs IDYA Comparison

HSAI vs IDYA Comparison

Compare HSAI & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSAI
  • IDYA
  • Stock Information
  • Founded
  • HSAI 2014
  • IDYA 2015
  • Country
  • HSAI China
  • IDYA United States
  • Employees
  • HSAI N/A
  • IDYA N/A
  • Industry
  • HSAI
  • IDYA Biotechnology: Pharmaceutical Preparations
  • Sector
  • HSAI
  • IDYA Health Care
  • Exchange
  • HSAI Nasdaq
  • IDYA Nasdaq
  • Market Cap
  • HSAI 1.8B
  • IDYA 1.5B
  • IPO Year
  • HSAI 2023
  • IDYA 2019
  • Fundamental
  • Price
  • HSAI $15.30
  • IDYA $19.00
  • Analyst Decision
  • HSAI
  • IDYA Strong Buy
  • Analyst Count
  • HSAI 0
  • IDYA 13
  • Target Price
  • HSAI N/A
  • IDYA $53.58
  • AVG Volume (30 Days)
  • HSAI 5.9M
  • IDYA 1.7M
  • Earning Date
  • HSAI 05-19-2025
  • IDYA 05-06-2025
  • Dividend Yield
  • HSAI N/A
  • IDYA N/A
  • EPS Growth
  • HSAI N/A
  • IDYA N/A
  • EPS
  • HSAI N/A
  • IDYA N/A
  • Revenue
  • HSAI $284,577,139.00
  • IDYA $7,000,000.00
  • Revenue This Year
  • HSAI $68.02
  • IDYA $121.20
  • Revenue Next Year
  • HSAI $34.07
  • IDYA $302.20
  • P/E Ratio
  • HSAI N/A
  • IDYA N/A
  • Revenue Growth
  • HSAI 10.66
  • IDYA N/A
  • 52 Week Low
  • HSAI $3.52
  • IDYA $13.45
  • 52 Week High
  • HSAI $24.18
  • IDYA $44.42
  • Technical
  • Relative Strength Index (RSI)
  • HSAI 52.40
  • IDYA 59.35
  • Support Level
  • HSAI $10.41
  • IDYA $15.84
  • Resistance Level
  • HSAI $16.33
  • IDYA $20.08
  • Average True Range (ATR)
  • HSAI 1.60
  • IDYA 1.36
  • MACD
  • HSAI 0.37
  • IDYA 0.50
  • Stochastic Oscillator
  • HSAI 82.60
  • IDYA 83.71

About HSAI Hesai Group each ADS represents one Class B ordinary share

Hesai Group is engaged in the development, manufacture, and sales of three dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. The Group organized its operations into two segments: the LiDAR segment and the gas detection segment, out of which LiDAR segments derives maximum revenue. Geographically, the company operates into North America, Mainland China, Europe and Other regions.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: